Indicators

Markets:

News

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9

...

CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans

May 01, 2025

Novo Nordisk opens weight loss drug Wegovy to Hims & Hers, Ro and Life MD telehealth

April 29, 2025

Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic

April 25, 2025

Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma

April 22, 2025

5 European stocks to watch this earnings season as Trump's tariffs hit

April 22, 2025

Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients

April 17, 2025

CNBC Daily Open: Consumers are worried over the economy. The White House insists it’ll be fine

April 14, 2025

Pfizer scraps daily weight loss pill after liver injury in one patient

April 14, 2025

Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkback

April 10, 2025

Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound

April 04, 2025

The biggest winners and losers in Europe as Trump announces sweeping tariffs

April 03, 2025

Pharma tariff relief likely short-lived with sector-specific duties on the horizon

April 03, 2025

Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years

March 29, 2025

Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'

March 28, 2025

Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action

March 27, 2025

CNBC Daily Open: Consumers and CFOs alike are expecting a recession in the U.S.

March 26, 2025

CNBC Daily Open: Fears of a U.S. recession intensify among consumers and CFOs

March 25, 2025

Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly

March 25, 2025

Software giant SAP becomes Europe's most valuable firm amid German stock market boom

March 25, 2025

Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer

March 24, 2025

Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure

March 24, 2025

Zepbound copycats remain online despite FDA ban

March 21, 2025

Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests

March 11, 2025

5 things to know before the stock market opens Monday

March 10, 2025

Novo Nordisk shares fall 5.5% after latest trial results for its next-generation weight loss drug

March 10, 2025

Amgen starts two critical late-stage trials for weight loss drug MariTide

March 05, 2025

Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy

March 05, 2025

Healthy Returns: AbbVie is the newest potential weight loss drug market player

March 04, 2025

Eli Lilly plans at least $27 billion in new U.S. manufacturing investments

February 26, 2025

Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

February 21, 2025

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.